However, all compounds that have entered clinical development for the treatment of insomnia target both receptors, and it is important to note that, if disruption of the Hcrt transmission may cause destabilization of the boundaries between sleep states, some serious concerns may be raised regarding the use of anti-Hcrt medications for alleviating signs of drug dependence. The gene discussed is HCRT; the disease is insomnia.